Pfizer will create an end-to-end business organization called the Pfizer Oncology Division, which will integrate certain oncology commercial and R&D operations from both companies and will be led by Chris Boshoff, who will become Chief Oncology Officer and Executive Vice President. 

Pfizer will split its non-oncology commercial organization into two more focused business divisions: 

• Pfizer U.S. Commercial Division, which will be led by Aamir Malik, who will become Chief U.S. Commercial Officer and Executive Vice President.
• Pfizer International Commercial Division will be led by Alexandre de Germay, who will join Pfizer as Chief International Commercial Officer and Executive Vice President.

The new organizational structure will go into effect on January 1, 2024.

Angela Hwang, Chief Commercial Officer and President Global Biopharmaceuticals Business, will leave Pfizer. 

Price Action: SGEN shares are up 3.26% at $228.83, and PFE shares are up 0.02% at $28.65 on the last check Tuesday.

Photo Via Company